Published in Surg Obes Relat Dis on June 09, 2009
Clinical Benefit of Gastric Staple Line Reinforcement (SLR) in Gastrointestinal Surgery: a Meta-analysis. Obes Surg (2015) 2.23
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. Wideochir Inne Tech Maloinwazyjne (2012) 1.42
Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol (2013) 1.21
Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese. Surg Endosc (2011) 1.16
Removable and repositionable covered metal self-expandable stents for leaks after upper gastrointestinal surgery: experiences in a tertiary referral hospital. Surg Endosc (2013) 1.15
Laparoscopic re-sleeve gastrectomy as a treatment of weight regain after sleeve gastrectomy. World J Gastrointest Surg (2014) 1.04
Sleeve gastrectomy and Roux-en-Y gastric bypass exhibit differential effects on food preferences, nutrient absorption and energy expenditure in obese rats. Int J Obes (Lond) (2012) 1.03
Laparoscopic sleeve gastrectomy feasible for bariatric revision surgery. Obes Surg (2012) 0.99
Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc (2012) 0.99
Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? World J Gastroenterol (2015) 0.98
The effect of laparoscopic sleeve gastrectomy on the antireflux mechanism: can it be minimized? Surg Endosc (2013) 0.96
A systematic review of staple-line reinforcement in laparoscopic sleeve gastrectomy. JSLS (2013) 0.92
Early results of a Canadian laparoscopic sleeve gastrectomy experience. Can J Surg (2011) 0.91
Changes in obesity-related diseases and biochemical variables after laparoscopic sleeve gastrectomy: a two-year follow-up study. BMC Surg (2014) 0.90
The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material. Obes Surg (2012) 0.89
Sleeve gastrectomy in older obese patients. Surg Endosc (2013) 0.89
Redesigning the process of laparoscopic sleeve gastrectomy based on risk analysis resulted in 100 consecutive procedures without complications. Wideochir Inne Tech Maloinwazyjne (2013) 0.88
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? Int J Obes (Lond) (2013) 0.86
The Initial Learning Curve for Robot-Assisted Sleeve Gastrectomy: A Surgeon's Experience While Introducing the Robotic Technology in a Bariatric Surgery Department. Minim Invasive Surg (2012) 0.86
Major complications of bariatric surgery: endoscopy as first-line treatment. Nat Rev Gastroenterol Hepatol (2015) 0.84
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice. Hepatology (2016) 0.84
Staple-line reinforcement during laparoscopic sleeve gastrectomy using three different techniques: a randomized trial. Surg Endosc (2012) 0.83
BariSurg trial: Sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35-60 kg/m(2) - a multi-centre randomized patient and observer blind non-inferiority trial. BMC Surg (2015) 0.83
Metabolic effects of sleeve gastrectomy in female rat model of diet-induced obesity. Surg Obes Relat Dis (2011) 0.81
Laparoscopic sleeve gastrectomy in adult and pediatric obese patients: a comparative study. Surg Endosc (2012) 0.80
Sleeve gastrectomy or gastric bypass as revisional bariatric procedures: retrospective evaluation of outcomes. Surg Endosc (2013) 0.78
Laparoscopic sleeve gastrectomy: perioperative outcomes, weight loss and impact on type 2 diabetes mellitus over 2 years. Can J Surg (2014) 0.78
Residual fundus or neofundus after laparoscopic sleeve gastrectomy: is fundectomy safe and effective as revision surgery? Surg Endosc (2014) 0.78
Place of upper endoscopy before and after bariatric surgery: A multicenter experience with 3219 patients. World J Gastrointest Endosc (2016) 0.78
To Sleeve or NOT to Sleeve in Bariatric Surgery? ISRN Surg (2012) 0.77
The impact of selected factors on parameters of weight loss after sleeve gastrectomy. Wideochir Inne Tech Maloinwazyjne (2016) 0.77
Energy intake, nutritional status and weight reduction in patients one year after laparoscopic sleeve gastrectomy. Springerplus (2013) 0.77
Comparison of four different methods in staple line reinforcement during laparascopic sleeve gastrectomy. Int J Clin Exp Med (2013) 0.77
Laparoscopic sleeve gastrectomy as a primary operation for morbid obesity: experience with 200 patients. Gastroenterol Res Pract (2012) 0.77
The impact of laparoscopic sleeve gastrectomy on weight loss and obesity-associated comorbidities: the results of 3 years of follow-up. Surg Endosc (2015) 0.77
A working paradigm for the treatment of obesity in gastrointestinal practice. Tech Gastrointest Endosc (2017) 0.77
Comparison of mini-gastric bypass with sleeve gastrectomy in a mainly super-obese patient group: first results. Surg Endosc (2016) 0.76
Development of minimally invasive techniques for management of medically-complicated obesity. World J Gastroenterol (2014) 0.76
A matched cohort analysis of single anastomosis loop duodenal switch versus Roux-en-Y gastric bypass with 18-month follow-up. Surg Endosc (2015) 0.76
Excess Body Mass Index Loss at 3 Months: A Predictive Factor of Long-Term Result after Sleeve Gastrectomy. J Obes (2017) 0.75
Bariatric surgery in the Caribbean: is it safe in a low-volume, third world setting? Minim Invasive Surg (2012) 0.75
Most common robotic bariatric procedures: review and technical aspects. Ann Surg Innov Res (2015) 0.75
MEDIUM-TERM FOLLOW-UP RESULTS WITH LAPAROSCOPIC SLEEVE GASTRECTOMY. Arq Bras Cir Dig (2015) 0.75
Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux. Electron Physician (2017) 0.75
Prediction Model for Hemorrhagic Complications after Laparoscopic Sleeve Gastrectomy: Development of SLEEVE BLEED Calculator. Obes Surg (2016) 0.75
Bariatric Surgery and Kidney-Related Outcomes. KI Rep (2017) 0.75
Impact of preoperative body mass index on the final outcome after laparoscopic sleeve gastrectomy for morbid obesity. Ulus Cerrahi Derg (2016) 0.75
Impact of obesity treatment on gastroesophageal reflux disease. World J Gastroenterol (2016) 0.75
Endoscopic Abscess Septotomy for Management of Sleeve Gastrectomy Leak. Obes Surg (2017) 0.75
Endoscopic Treatments for Obesity. Curr Treat Options Gastroenterol (2017) 0.75
Shorter than 24-h hospital stay for sleeve gastrectomy is safe and feasible. Surg Endosc (2016) 0.75
Incidental Finding of Gastrointestinal Stromal Tumors during Laparoscopic Sleeve Gastrectomy in Obese Patients. Obes Surg (2017) 0.75
The effect of rs9939609 FTO gene polymorphism on weight loss after laparoscopic sleeve gastrectomy. Surg Endosc (2015) 0.75
Management Options for Twisted Gastric Tube after Laparoscopic Sleeve Gastrectomy. Obes Surg (2017) 0.75
Endoscopic management of post-laparoscopic sleeve gastrectomy stenosis. Surg Endosc (2016) 0.75
Preoperative Weight Loss and Operative Outcome After Laparoscopic Sleeve Gastrectomy. Obes Surg (2017) 0.75
15-year follow-up of vertical banded gastroplasty: comparison with other restrictive procedures. Surg Endosc (2015) 0.75
Laparoscopic Sleeve Gastrectomy in Kidney Transplant Candidates: a Case Series. Obes Surg (2017) 0.75
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg (2003) 4.30
The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg (2010) 3.37
Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care (2014) 3.13
Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med (2010) 2.90
Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab (2004) 2.36
Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med (2006) 2.31
Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem (2009) 2.11
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 1.86
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care (2013) 1.83
Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology (2002) 1.80
Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004. Arch Surg (2007) 1.80
Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol (2006) 1.78
The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg (2004) 1.77
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg (2005) 1.70
Risk and location of cancer in patients with preoperative colitis-associated dysplasia undergoing proctocolectomy. Ann Surg (2014) 1.58
Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis (2011) 1.53
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem. Antimicrob Agents Chemother (2005) 1.50
Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab (2010) 1.49
Gastrointestinal complications of laparoscopic Roux-en-Y gastric bypass surgery: clinical and imaging findings. Radiology (2002) 1.46
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology (2006) 1.46
Medium-term follow-up confirms the safety and durability of laparoscopic ventral hernia repair with PTFE. Surgery (2003) 1.44
Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery (2007) 1.41
The presence of primary sclerosing cholangitis is protective for ileal pouch from Crohn's disease. Inflamm Bowel Dis (2013) 1.39
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia. Antimicrob Agents Chemother (2011) 1.25
Bariatric surgery and cardiovascular outcomes: a systematic review. Heart (2012) 1.24
Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension. Eur Respir J (2013) 1.20
Laparoscopic era of operations for morbid obesity. Arch Surg (2003) 1.15
Tubal anastomosis by robotic compared with outpatient minilaparotomy. Obstet Gynecol (2007) 1.14
Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol (2011) 1.13
Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline. Antimicrob Agents Chemother (2011) 1.12
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother (2011) 1.10
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Laparoscopic sleeve gastrectomy for super obese patients: forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg (2012) 1.09
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis (2006) 1.08
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring) (2009) 1.08
Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statistics. Antimicrob Agents Chemother (2011) 1.07
Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis (2010) 1.05
Multivariable analysis of factors associated with hospital readmission after intestinal surgery. Am J Surg (2006) 1.05
Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg (2004) 1.03
Congenital cholesteatoma: classification, management, and outcome. Arch Otolaryngol Head Neck Surg (2002) 1.02
Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) (2011) 1.02
Clinical outcomes and cost analysis of a "fast track" postoperative care pathway for ileal pouch-anal anastomosis: a case control study. Dis Colon Rectum (2007) 1.02
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens. Clin Infect Dis (2003) 1.01
Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc (2011) 1.00
Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis (2006) 0.99
Revisional bariatric surgery for unsuccessful weight loss and complications. Obes Surg (2013) 0.99
Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg (2010) 0.99
Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg (2003) 0.96
Pancreatic islet isolation after gastric bypass in a rat model: technique and initial results for a promising research tool. Surg Obes Relat Dis (2010) 0.95
Is urethral mobility really being assessed by the pelvic organ prolapse quantification (POP-Q) system? Obstet Gynecol (2002) 0.93
Jejunal gastrointestinal stromal tumor: a cause of obscure gastrointestinal bleeding. Arch Pathol Lab Med (2004) 0.92
Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2). J Obes (2012) 0.91
Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis (2012) 0.90
Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving ≥5 years after baseline right-sided cardiac catheterization. Am J Cardiol (2012) 0.90
Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)--a multivariate analysis. Surgery (2006) 0.90
Can Sleeve Gastrectomy "Cure" Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes. Ann Surg (2016) 0.89
Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis (2008) 0.89
Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery. Obesity (Silver Spring) (2015) 0.88
Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis (2005) 0.88
Complications of gastric bypass: avoiding the Roux-en-O configuration. Obes Surg (2009) 0.87
Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity (Silver Spring) (2009) 0.87
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis (2012) 0.87
Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery. Obes Surg (2012) 0.86
Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis (2010) 0.86
Quality of life after antireflux surgery compared with nonoperative management for severe gastroesophageal reflux disease. J Am Coll Surg (2002) 0.85
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.85
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia. Antimicrob Agents Chemother (2013) 0.83
Weighing the evidence for an association between obesity and suicide risk. Surg Obes Relat Dis (2011) 0.83
A pilot study of health education via a nurse-run telephone self-management programme for elderly people with osteoarthritis. J Telemed Telecare (2004) 0.83
Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc (2014) 0.83
Nonreversal of Hartmann's procedure for diverticulitis: derivation of a scoring system to predict nonreversal. Dis Colon Rectum (2009) 0.83
Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese. Surg Obes Relat Dis (2011) 0.81
Bariatric surgery training: getting your ticket punched. J Gastrointest Surg (2007) 0.81
Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. Surg Obes Relat Dis (2011) 0.81
Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. Am J Gastroenterol (2009) 0.81
Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg (2011) 0.81
International Diabetes Federation position statement on bariatric surgery for type 2 diabetes: implications for patients, physicians, and surgeons. Surg Obes Relat Dis (2011) 0.81
Nurses's knowledge of heart failure education principles. Heart Lung (2002) 0.81
Outcomes after minimally invasive reoperation for gastroesophageal reflux disease. Ann Thorac Surg (2002) 0.80
Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve. Acta Diabetol (2014) 0.80
Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis. J Biol Chem (2013) 0.80
Surgical management of obesity and the relationship to cardiovascular disease. Circulation (2013) 0.79
Surgical management of early small bowel obstruction after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis (2012) 0.79
Medicare and bariatric surgery. Surg Obes Relat Dis (2006) 0.79
Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. Obes Surg (2012) 0.79
Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. J Crohns Colitis (2013) 0.78
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia. Diagn Microbiol Infect Dis (2008) 0.78
Postoperative radiotherapy for stage IIIA rectal cancer: is it justified? Dis Colon Rectum (2008) 0.78
Endoscopy and upper gastrointestinal contrast studies are complementary in evaluation of weight regain after bariatric surgery. Surg Obes Relat Dis (2006) 0.78
Gastrostomy tube placement in gastric remnant at gastric bypass: a rat model for selective gut stimulation. Surg Obes Relat Dis (2011) 0.77
Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures. Dig Dis Sci (2014) 0.77
Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch. Inflamm Bowel Dis (2009) 0.77
Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for Post-discharge Pharmacoprophylaxis. Ann Surg (2017) 0.77
Effect of small bowel obstruction on functional outcome and quality of life in patients with ileal pouch-anal anastomosis: 10-year follow-up study. J Gastroenterol Hepatol (2008) 0.76
Basal and postglucagon C-peptide levels in Ethiopians with diabetes. Diabetes Care (2002) 0.76
Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn's proctocolitis patients. J Am Coll Surg (2009) 0.76